Ovarian suppression for early breast cancer

Lancet. 2007 May 19;369(9574):1668-70. doi: 10.1016/S0140-6736(07)60758-2.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Agents, Hormonal / therapeutic use
  • Aromatase Inhibitors / therapeutic use
  • Breast Neoplasms / drug therapy*
  • Chemotherapy, Adjuvant*
  • Combined Modality Therapy
  • Gonadotropin-Releasing Hormone / analogs & derivatives*
  • Humans
  • Premenopause
  • Randomized Controlled Trials as Topic
  • Receptors, Estrogen / drug effects
  • Tamoxifen / therapeutic use

Substances

  • Antineoplastic Agents, Hormonal
  • Aromatase Inhibitors
  • Receptors, Estrogen
  • Tamoxifen
  • Gonadotropin-Releasing Hormone